Embecta Corp (EMBC) Financial Statements

EMBC Financial Data

EBITDA$320.10M

Revenue (TTM)$1.04B

Gross Profit (TTM)$645.10M

Gross Margin—

Operating Margin22.41%

ROE—

ROA10.26%

Debt/Equity—

Current Ratio2.41

FCF$182.40M

FCF Yield98.09%

Piotroski F-Score—

Rev/Share (TTM)$17.60

50-Day MA$8.04

200-Day MA$11.33

Shares Outstanding0.06B

EMBC Computed Insights

FCF$182.40M

FCF Growth Rate-13.62%

EPS Growth (CAGR)-22.25%

WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

EMBC Financial Statements & Data

Embecta Corp (EMBC) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Embecta Corp's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $1.04B. Gross profit (TTM) is $645.10M. EBITDA is $320.10M. Earnings per share (EPS) is $1.62. The P/E ratio is 1.66. Market capitalization is $185.95M.

Free cash flow (FCF) is $182.40M. FCF growth rate is -13.62%. EPS growth CAGR is -22.25%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Embecta Corp's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.